143 related articles for article (PubMed ID: 23119458)
1. Lead article: The prognostic significance of proliferating cell nuclear antigen (pcna) in laryngeal cancer.
Sapci T; Filizel F; Karavus A; Akbulut UG; Karavus M
Indian J Otolaryngol Head Neck Surg; 1998 Oct; 50(4):354-61. PubMed ID: 23119458
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results of prognostic significance of proliferating cell nuclear antigen expression in advanced primary larynx carcinomas and lymph node metastases.
Kupisz K; Stepulak A; Zdunek M; Klatka J
Arch Med Sci; 2010 Mar; 6(1):65-70. PubMed ID: 22371722
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of PCNA expression in laryngeal cancer.
Saraç S; Ayhan A; Hosal AS; Kaya S
Arch Otolaryngol Head Neck Surg; 1998 Dec; 124(12):1321-4. PubMed ID: 9865753
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx.
Dobroś W; Ryś J; Niezabitowski A; Olszewski E
Auris Nasus Larynx; 1998 Sep; 25(3):295-301. PubMed ID: 9799997
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
[TBL] [Abstract][Full Text] [Related]
7. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
Franchi A; Gallo O; Boddi V; Santucci M
Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer.
Morawski K; Gabriel A; Namyslowski G; Ziólkowski A; Pietrawska V; Steplewska K
Eur Arch Otorhinolaryngol; 1999; 256(8):378-83. PubMed ID: 10525938
[TBL] [Abstract][Full Text] [Related]
9. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.
Hu L; Li HL; Li WF; Chen JM; Yang JT; Gu JJ; Xin L
World J Gastroenterol; 2017 May; 23(20):3721-3729. PubMed ID: 28611525
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection a favorable prognostic factor in laryngeal squamous cell carcinoma is associated with the expression of proliferating cell nuclear antigen.
Jiang H; Lin PF
Pak J Med Sci; 2013 Sep; 29(5):1173-7. PubMed ID: 24353714
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases.
Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
Ann Surg; 2000 Jul; 232(1):112-8. PubMed ID: 10862203
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szkudlarek T; Jeleń-Krzeszewska J
Oral Oncol; 1999 Mar; 35(2):180-6. PubMed ID: 10435153
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical markers of cell proliferation in laryngeal carcinoma].
Urpegui García AM; Morandeira García MJ; Soria Navarro J; Rivas Rodríguez P; Valencia Julve J; Fernández Larripa S; Vallés Varela H
Acta Otorrinolaringol Esp; 2000 May; 51(4):279-87. PubMed ID: 10984949
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of PCNA and mutant p53 expression in laryngeal squamous cell carcinoma.
Buyukbayram H; Cureoglu S; Arslan A; Işikakdogan AR
Cancer Invest; 2004; 22(2):195-202. PubMed ID: 15199601
[TBL] [Abstract][Full Text] [Related]
16. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
17. [Expression and prognosis significance of p73 and PCNA in laryngeal squamous cell carcinoma].
Li J; Jiang X; Zhou X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Dec; 19(24):1121-4. PubMed ID: 16512489
[TBL] [Abstract][Full Text] [Related]
18. [The expression of p21(WAF1/CIP1) and PCNA in hypopharyngeal and laryngeal squamous cell carcinomas].
Li X; Tadashi N; Dong P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Feb; 19(3):97-9. PubMed ID: 15844604
[TBL] [Abstract][Full Text] [Related]
19. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
20. Correlation of proliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma.
Boran C; Yildiz L; Kandemir B; Karagoz F; Baris S; Aydin O
Neoplasma; 2003; 50(2):139-43. PubMed ID: 12740649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
